Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 7.86Arvee Laboratories demonstrates a mixed financial performance. The company shows strength in solvency and profitability, indicating a solid foundation and efficient operations. Growth metrics are also strong, particularly in revenue and earnings per share. However, efficiency ratios are weak, suggesting challenges in asset utilization. Liquidity is reasonable, providing some financial flexibility. The company maintains a strong interest coverage ratio, but does not distribute dividends. This overview suggests that Arvee Laboratories has robust profitability and growth potential, but needs to improve its operational efficiency to achieve more balanced financial health. While adjusted EPS and book value per share are low, capital expenditures are managed effectively. Overall, the company presents a promising investment opportunity with some operational areas needing attention.
Health Score : 7.86Arvee Laboratories demonstrates a mixed financial performance. The company shows strength in solvency and profitability, indicating a solid foundation and efficient operations. Growth metrics are also strong, particularly in revenue and earnings per share. However, efficiency ratios are weak, suggesting challenges in asset utilization. Liquidity is reasonable, providing some financial flexibility. The company maintains a strong interest coverage ratio, but does not distribute dividends. This overview suggests that Arvee Laboratories has robust profitability and growth potential, but needs to improve its operational efficiency to achieve more balanced financial health. While adjusted EPS and book value per share are low, capital expenditures are managed effectively. Overall, the company presents a promising investment opportunity with some operational areas needing attention.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
72.29
Industry Median
35.74
Small Cap Median
33.85
P/E RATIO
71.98
P/B RATIO
5.39
Industry Median
2.65
Small Cap Median
2.54
P/S RATIO
5.46
Industry Median
2.40
Small Cap Median
2.03
Others
PEG RATIO
-62.59
EV/EBITDA RATIO
43.93
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹165.55 as on Aug 17, 2026.
Growth Score : 8.00Arvee Laboratories exhibits strong growth in revenue and earnings per share, indicating a positive trajectory in core business performance. However, the operating profit growth rate and asset growth rate are low, suggesting potential challenges in profitability and asset expansion. The weighted average calculation underscores the recent growth trends and areas needing improvement. The company shows good growth in revenue and has potential for future growth. The company is financially stable.
Revenue Growth RateExcellentOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthExcellentAsset Growth RatePoorNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | -14.88 | 52.12 | -50.53 | 26.82 | -18.13 |
| Operating Profit Growth Rate | -6.43 | 28.35 | -59.67 | 22.79 | -11.63 |
| Earnings Per Share (EPS) Growth | -4.12 | 60.52 | -74.6 | 105.26 | 17.95 |
| Asset Growth Rate | -5.77 | 0.03 | -0.34 | -2.54 | 15.11 |
| Net Income Growth Rate | -4.1 | 60.31 | -74.51 | 104.76 | 17.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Arvee Laboratories (India) Ltd | 7.86 | 71.98 | Highly Overvalued | 3.19 | 2.29 | 2.53 |
| 2 | Diamines & Chemicals Ltd | 7.37 | -18.56 | Neutral | -14.00 | -11.05 | -13.00 |
| 3 | Indian Emulsifiers Ltd | 7.24 | 4.56 | Neutral | 26.00 | 8.84 | 16.00 |
| 4 | Vital Chemtech Ltd | 7.20 | 25.50 | Neutral | 10.00 | 3.74 | 1.00 |
| 5 | Ambani Orgochem Ltd | 5.39 | 66.09 | Neutral | 16.00 | 1.77 | 1.00 |
| 6 | Hindcon Chemicals Ltd | 5.31 | 35.13 | Neutral | 3.66 | 0.63 | 3.08 |
| 7 | Alkali Metals Ltd | 5.12 | -17.05 | Neutral | 7.72 | 0.55 | 0.56 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Arvee Laboratories (India) Ltd is a specialty chemical manufacturer focusing on pharmaceutical intermediates, bulk drugs, and custom synthesis. Serving diverse industries like pharmaceuticals, agrochemicals, and pigments, the company leverages its R&D capabilities to offer tailored chemical solutions and contribute to various critical supply chains.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Arvee Laboratories (India) Ltd's P/E ratio (TTM) is 72.29, compared to the industry median of 35.74 and large cap median of 33.85.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Arvee Laboratories (India) Ltd's P/B ratio is 5.39, compared to the industry median of 2.65 and large cap median of 2.54.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Arvee Laboratories (India) Ltd's P/S ratio is 5.46, compared to the industry median of 2.40 and large cap median of 2.03.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Arvee Laboratories (India) Ltd's PEG ratio is -62.59.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Arvee Laboratories (India) Ltd's EV/EBITDA ratio is 43.93.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Arvee Laboratories (India) Ltd's ROE is 7.49%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Arvee Laboratories (India) Ltd's ROA is 7.37%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Arvee Laboratories (India) Ltd's ROCE is 7.92%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Arvee Laboratories (India) Ltd's operating margin is 10.12%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Arvee Laboratories (India) Ltd's net margin is 8.03%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Arvee Laboratories (India) Ltd's current ratio is 3.07.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Arvee Laboratories (India) Ltd's debt-to-equity ratio is 0.03.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Arvee Laboratories (India) Ltd's interest coverage ratio is 11.57.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Arvee Laboratories (India) Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Arvee Laboratories (India) Ltd's EPS is 17.95.
(Source line: "Ratios as of 17 Aug 2026, based on last traded price of ₹165.55. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Arvee Laboratories (India) Ltd was incorporated in 1992, establishing its manufacturing facility primarily for pharmaceutical intermediates. Over the years, the company expanded its product portfolio to include bulk drugs and a variety of specialty chemicals. It has consistently focused on R&D and custom synthesis to provide tailored chemical solutions, serving critical supply chains in the pharmaceutical, agrochemical, and other industrial sectors.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pharmaceutical Intermediates & Bulk Drugs | Approx. 65% | Operating Profit |
| Specialty Chemicals & Custom Synthesis | Approx. 35% | Operating Profit |
Mr. V. Subbanna, Chairman & Managing Director. As the founder, he has been instrumental in establishing and growing Arvee Laboratories, overseeing its strategic direction, operational excellence, and product development in the specialty chemical and pharmaceutical intermediate sectors.
No major subsidiaries reported.
No major recent corporate actions on record.
References
The Arvee Laboratories (India) Ltd share price today is ₹165.55 on NSE (ARVEE), as of 18 Aug 2026.
As of 17 Aug 2026, Arvee Laboratories (India) Ltd share price is ₹165.55, with previous close ₹N/A. Today's range is ₹N/A to ₹N/A. The 52-week range is ₹N/A to ₹N/A.
As of today, Arvee Laboratories (India) Ltd's market cap is ₹172.17 crore (Small Cap).
Arvee Laboratories (India) Ltd's current P/E ratio is 72.29, compared to the CHEMICALS & PETROCHEMICALS sector average of 26.80.
Arvee Laboratories (India) Ltd's current P/B ratio is 5.39.
Arvee Laboratories (India) Ltd's current dividend yield is N/A. Last dividend of ₹0.50 per share was declared on 07-Sep-2023.
Arvee Laboratories (India) Ltd's EPS (TTM) is ₹17.95.
Arvee Laboratories (India) Ltd is a specialty chemical manufacturer focusing on pharmaceutical intermediates, bulk drugs, and custom synthesis. Serving diverse industries like pharmaceuticals, agrochemicals, and pigments, the company leverages its R&D capabilities to offer tailored chemical solutions and contribute to various critical supply chains.
Arvee Laboratories (India) Ltd is promoted by V. Subbanna and Family, holding 73.5% as of 17 Aug 2026.
Arvee Laboratories (India) Ltd is listed on NSE (ARVEE) and BSE ({bse}). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Capital Expenditures (CapEx)
Inventory Turnover Ratio